5
Participants
Start Date
May 31, 2013
Primary Completion Date
August 30, 2019
Study Completion Date
August 30, 2019
Topical timolol maleate
"* Topical timolol maleate 0.5% drops~* Applied twice daily for 12 weeks (84 days) or until disappearance of lesions~* Study drops will be applied to 3 cutaneous telangiectasias per patient"
placebo saline drops
Applied twice daily for 12 weeks (84 days) or until disappearance of lesions to 1 cutaneous telangiectasias per patient.
St. Michael's Hospital, Toronto
University of California, San Francisco
OTHER
The Hospital for Sick Children
OTHER
University of Toronto
OTHER
Sunnybrook Health Sciences Centre
OTHER
Toronto Metropolitan University
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Unity Health Toronto
OTHER